On 17 November 2020, a virtual sponsored symposium will be held in conjunction with the ASTMH Annual Meeting, focusing on re-starting malaria R&D in the face of COVID in Africa. 

COVID-19 has put a halt to much of the health research happening worldwide. It is vital that malaria R&D and clinical trials are re-started as soon as possible to ensure we do not lose valuable time bringing much needed innovations, such as new drugs and insecticides, to market. This symposium will share perspectives from research programmes on how COVID-19 has affected their operations and their planning for re-starting R&D in a safe and effective manner.

Register here and find out more information on the ASTMH Annual Meeting here.